Angiotensin-(1-7)
Angiotensin-(1-7) is a pharmaceutical drug with 10 clinical trials. Currently 4 active trials ongoing. Historical success rate of 25.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
20.0%
1 of 5 finished
80.0%
4 ended early
4
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension
Angiotensin-(1-7) and Energy Expenditure in Human Obesity
Angiotensin-(1-7) Cardiovascular Effects in Aging
Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients
Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG
Clinical Trials (10)
Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension
Angiotensin-(1-7) and Energy Expenditure in Human Obesity
Angiotensin-(1-7) Cardiovascular Effects in Aging
Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients
Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG
Metabolic Effects of Angiotensin-(1-7)
Angiotensin 1-7 in Obesity Hypertension
Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients
Use of Angiotensin-(1-7) in COVID-19
Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10